Patt Morrison For February 1, 2012

Cancer charity Susan G. Komen yanks funding for Planned Parenthood

Israelis participate in a march organize

Gali Tibbon/AFP/Getty Images

Israelis participate in a march organized by Komen for the Cure, the world's largest breast cancer charity, as they walk around the walls of Jerusalem's Old City as part of "Race for the Cure" campaign to raise breast cancer awareness on October 28, 2010.

Backlash to the decision of leading breast-cancer charity Susan G. Komen for the Cure to cease providing grants to Planned Parenthood centers nationwide has been widespread, sparking further debate over abortion.

The decision, confirmed Tuesday by the Komen foundation, means hundreds of thousands of dollars in funding, mainly for services such as clinical breast exams and referrals for mammograms will be yanked. Planned Parenthood said the cancer charity has bowed to pressure from anti-abortion groups. A Komen spokeswoman said the cutoff stems from newly adopted criteria barring grants to organizations under investigation by state, local or federal authorities. Planned Parenthood is under investigation by Congress in a probe launched in September by Rep. Cliff Stearns (R-Fla.) to determine whether the reproductive health care provider uses public money to fund abortions. U.S. Senator Barbara Boxer (D-Calif.) said in a statement Wednesday, “I truly hope that they will reconsider this decision and put the needs of women first.” According to Planned Parenthood, more than 4 million breast exams were performed at its centers over the past five years, with nearly 170,000 as a result of Komen grants.

WEIGH IN:

Do you think the Komen foundation’s decision is unfair? Or does Komen have the right to pull funding given the foundation’s criteria due to a federal investigation into Planned Parenthood?

Guest:

Sue Dunlap, president, CEO, Planned Parenthood Los Angeles

Susan Wood, professor of health policy, George Washington University; former director of the women’s health office, FDA


blog comments powered by Disqus